The article " Moderna: A Generational Opportunity for Investors in 2025 " first appeared on MarketBeat.

Following a lackluster 2024, shares of major drugmakers kicked off 2025 with an upbeat quarterly results reading. U.S. pharmaceuticals like Eli Lilly (LLY), Johnson & Johnson (JNJ), Bristol-Myers ...

Medics in the UK have become the first in the world to successfully administer a pioneering gene therapy that preserves sight in young children with an extremely rare genetic condition that usually ...

Ruby Jackson explores the importance of happy accidents in scientific research ...

This stock can be held in an Investment ISA and an Investment Account ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative strength and extensive intellectual property portfolioThe company holds one of th ...

Highlights,Institutional investors such as Rhumbline Advisers adjusted their stake, reducing shares in the last ...

Electric vehicle maker Tesla (TSLA) has been named the best stock for investors to short right now by Wolfe Research.Maximize ...

Jerry Butler, a premier soul singer whose rich, steady baritone graced such hits as "For Your Precious Love," "Only the ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...